AMRRoche presents restistance-breaking antibioticLatest NewsHoffmann-La Roche AG has published details on the mechanism of action of its Phase I antibiotic Zosurabalpin (RG6006) that kills the carbapenem-resistant bug Acinetobacter baumannii. . Read more 3 January 2024 https://european-biotechnology.com/wp-content/uploads/2024/04/A.baumannii_visualized_using_Scanning_electron_microscopy.png 768 1024 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2024-01-03 08:56:002024-07-09 12:29:38Roche presents restistance-breaking antibiotic